In conclusion, this study highlights that elevated humoral responses against pHERV-Wenv and syncytin-1 in MS patients, particularly those with progressive forms, support the involvement of pHERV-W in MS pathogenesis. The gene discussed is ERVW-1; the disease is myeloid sarcoma.